Gastroenterology News

The addition of nivolumab to ipilimumab significantly improved OS among adults with previously untreated advanced hepatocellular carcinoma, according to a release by the agent’s manufacturer.

Despite being considered a fairly rare disease, the incidence of anal cancer has doubled over the last 30 years, with the American Cancer Society estimating approximately 10,540 new cases and 2,190 related deaths in 2024.

When I first entered the medical profession more than 30 years ago, I was taken by the amount of trash that was produced in the emergency department where I volunteered.

In this Healio video exclusive, Sudha Pandit, MD, reports that the survival rate for colorectal cancer “is over 91%” if caught early, an important reminder during Colorectal Cancer Awareness Month.

The CDC published a guide that hospitals can use to reduce the risk for burnout among health care staff.

A “significantly greater” percentage of patients with primary biliary cholangitis achieved biochemical response, alkaline phosphatase normalization and reduction in pruritis when treated with seladelpar vs. placebo, according to a study.

In a Healio video exclusive, Edward V. Loftus Jr., MD, urged gastroenterologists to prioritize identifying food triggers and recommending dietary interventions and behavioral therapy for patients with irritable bowel syndrome.

Treating patients with irritable bowel syndrome can be a challenge for health care providers, as patients with suspected IBS often report a lengthy list of visceral and somatic symptoms that can overwhelm a busy provider.

Results from a 2023 nationwide survey published in Gastroenterology estimated the prevalence of Rome IV irritable bowel syndrome in the U.S. climbing to 6.1% — higher than previous reports of 4.7% to 5.3%.

The FDA approved tislelizumab-jsgr as a monotherapy for the treatment of certain adults with unresectable or metastatic esophageal squamous cell carcinoma, according to a press release.